Rating History for Denali Therapeutics Inc. (DNLI) by UBS

More Stocks Rated by UBS | Latest Ratings for DNLI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/16/2026 Michael Yee Maintain Buy
(Buy)		 25.00
(25.00)		  
 		   Details